Wang Zhi-Ji, Kim Eun-Seong, Noh Byoungho H, Liang Jun-Ge, Lee Dongpyo, Hur Yun Jung, Kim Nam-Young, Kim Heung-Dong
RFIC Center, Kwangwoon University, 447-1 Wolgye-Dong, Nowon-Ku, Seoul 139-701, Republic of Korea. These authors contributed equally to this work.
J Neural Eng. 2020 Jun 22;17(3):036014. doi: 10.1088/1741-2552/ab914f.
Vagus nerve stimulation (VNS) is a nonpharmacologic therapeutic option for patients who have pharmaco-resistant Dravet syndrome (DS). Plentiful efforts have been made for delivering VNS to DS patients, but its effectiveness still requires further verification. We investigated the effectiveness of the VNS treatment of DS patients using brain connectivity analysis with electroencephalography (EEG).
Twenty pharmaco-resistant DS patients were selected to undergo VNS implantation and classified into responder and non-responder groups after 24 months post-VNS. The effect of VNS between 6 months pre- and 6, 12, and 24 months post-VNS in all patients, responders, and non-responders on four different frequency categories of four brain parameters were compared using resting-state EEG.
In alpha and beta bands, all patients showed positive results for characteristic path length (CPL), global efficiency (GE), and transitivity after VNS treatment, and changes in betweenness centrality (BC) were not significant. The difference in transitivity between responders and non-responders is more pronounced than those in CPL and GE are, in both the alpha (p < 0.015) and beta (p < 0.001) bands. There was an obvious change in BC, especially in the alpha band, as the hubs tended to move from frontal lobe to parietal lobe for responders; however, there was no change for the non-responders.
We investigated the alteration in brain connectivity of DS patients in alpha and beta bands during a long-term follow-up and found the responders have a decreased transitivity after the VNS treatment. Moreover, the hubs with high values in the alpha band tended to move from frontal lobe to parietal lobe for responders after VNS treatment.
迷走神经刺激(VNS)是药物难治性德雷维特综合征(DS)患者的一种非药物治疗选择。为DS患者提供VNS治疗已付出诸多努力,但其有效性仍需进一步验证。我们使用脑电图(EEG)进行脑连接分析,研究VNS治疗DS患者的有效性。
选取20例药物难治性DS患者接受VNS植入,并在VNS治疗24个月后分为反应者组和无反应者组。使用静息态EEG比较所有患者、反应者和无反应者在VNS治疗前6个月以及治疗后6、12和24个月时,四种脑参数的四个不同频率类别上VNS的效果。
在α和β频段,所有患者在VNS治疗后特征路径长度(CPL)、全局效率(GE)和传递性均显示出阳性结果,而中介中心性(BC)的变化不显著。在α(p < 0.015)和β(p < 0.001)频段,反应者和无反应者之间传递性的差异比CPL和GE的差异更明显。BC有明显变化,尤其是在α频段,反应者的枢纽倾向于从额叶转移到顶叶;然而,无反应者则没有变化。
我们在长期随访中研究了DS患者α和β频段脑连接的变化,发现反应者在VNS治疗后传递性降低。此外,VNS治疗后,反应者在α频段具有高值的枢纽倾向于从额叶转移到顶叶。